News

Some families took advantage of beautiful weather in Louisville to enjoy a great Mother's Day.
May 12, 2025. More for You ...
Barbie-maker Mattel withdrew its annual financial targets on Monday and said it would increase prices for some products in ...
The bleak pandemic years of empty deckchairs, ghost-town resorts, and thumb-twiddling masseuses are now just a bad memory for ...
Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...
Lilly's Zepbound overtook Novo's Wegovy as the leading obesity drug, according to the latest prescription data last month. But Novo CEO Lars Jørgensen attributes the softness in sales to the ...
A team based at the University of Manchester, funded by Cancer Research UK, are designing a clinical trial involving tens of ...
Q1 Wegovy sales rose 85% to DKK 17.36 billion; Ozempic up 18% to DKK 32.72 billion. Novo Nordisk's Q1 sales hit $10.89 billion, missing the $11.64 billion consensus estimate. Don’t miss this ...
DEAR PEOPLE’S PHARMACY: I took Wegovy for a few months last fall until I was unable to find a pharmacy that could fill my prescription. They were all out of stock. I lost 17 pounds and my A1C ...
COPENHAGEN/LONDON (Reuters) -Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound copycats is enforced this month ...
Andrew Dudum, cofounder of San Francisco-based online pharmacy Hims & Hers, a seller of wellness products for men and women – including hair loss and erectile dysfunction pills – is now a ...
Novo Nordisk A/S NVO is seeking FDA approval for the pill version of its obesity drug, Wegovy. The company recently highlighted early data that shows safety and efficacy figures that are similar t ...